期刊文献+

氯氮平对儿童少年精神分裂症患者血清拟胆碱酯酶活性影响 被引量:2

THE INFLUENCE OF CLOZAPINE ON CHE OF HOBBLEDEHOY SCHIZOPHRENICS
下载PDF
导出
摘要 [目的]通过动态观察青少年精神分裂症患者氯氮平治疗后血清胆碱酯酶(CHE)的变化,了解药物作用机理和对肝脏的影响。[方法]选取未经治疗的首发青少年精神分裂症患者70例,于治疗前和治疗2周、3周、4周、5周、6周及7周以上时,检测患者血清胆碱酯酶(CHE),并同时于2、4、6、8周采用简明精神病评定量表(BPRS)和副反应量表(TESS)评定疗效和副反应。[结果]患者BPRS和TESS量表评分,治疗前后相比较差异均有统计学意义(P﹤0.05),治疗2周与其他周相比差异有统计学意义(P﹤0.05)。与治疗前相比CHE略有升高,但差异无统计学意义(P﹥0.05)。[结论]氯氮平治疗青少年精神分裂症疗效确切,但有可能增强肝脏合成脂蛋白的能力,从而导致脂类代谢紊乱。  [Objective]To test the change of CHE of the hobbledehoy schizophrenics treated by clozapine,and find out the its function mechanism and its influence on liver.[Methods]70 hobbledehoys who suffered from schizophrenia for the 1st time and had never been treated were sellected. The CHE of them were measured before and after 2,3,4,5,6 and 7 weeks of treatment,and the curative effect and side reaction were evaluated using BPRS and TESS after 2,4,6,8 weeks of treatment.[Results]Their was significant difference between the evaluation results of BPRS and TESS before and after treatment(P﹤0.05) and the results among the ones treated for 2 weaks or not(P﹤0.05). CHE was a little higher than that before treatment,but there was no statistical difference(P﹥0.05).[Conclusion]It is certain that clozapine has an effect on hobbledehoy schizophrenics,but it may enhance the ability of lipoprotein synthesis by liver,which results in the disorder of fat metabolism.
出处 《现代预防医学》 CAS 北大核心 2007年第18期3513-3514,共2页 Modern Preventive Medicine
关键词 儿童少年 精神分裂症 氯氮平 胆碱酯酶 Hobbledehoy Schizophrenia Clozapine Cholinesterase
  • 相关文献

参考文献8

二级参考文献25

  • 1虞琳,柯晓燕,罗硕军,杭跃跃,林节.奎硫平治疗儿童青少年精神分裂症研究[J].临床精神医学杂志,2004,14(6):340-341. 被引量:8
  • 2黄明生 邹文均.精神分裂症患者全血胆碱酯酶的初步研究[J].中华神经精神科杂志,1984,17(3):131-131.
  • 3BergerPA(陈关刚节译).精神分裂症的药物治疗[J].国外医学:精神病学分册,1982,9:107-107.
  • 4于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330
  • 5Kumra S, Herion D,Jacobsen LK,et al. Casestudy:Risperidone-induced hepatoxicity in pediatric patients[J]. Am child-Adolesc-Psychiatry,1997,36(5):701-706
  • 6Rutter M,Taylor E. Child and adolescent psychiatry[M].Forth ed.London:Blackwell Publishing,2002.612-630,998-1013.
  • 7Remschmidt H. Early-onset schizophrenia as a regressive-deteriorating developmental disorder: evidence from child psychiatry[J].J Neural Transm, 2002,109:101-117.
  • 8Clark AF,Lewis SW. Practitioner review:treatment of schizophrenia in childhood and adolescence[J].J Child Psychol Psychiatry,1998,39:1071-1081.
  • 9Gothelf D,Apter A,Reidman J,et al.Olanzapine,risperidone and haloperidol in the treatment of adolescent patients with schizophrenia[J].J Neural Transm,2003,110:545-560.
  • 10Frazier JA,Cohen LG,Jacobsen L,et al.Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia[J].J Clin Psychopharmacol,2003,23:87-91.

共引文献74

同被引文献13

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部